Comparing Revenue Performance: Bio-Techne Corporation or Perrigo Company plc?

A Tale of Two Companies: Bio-Techne vs. Perrigo

In the ever-evolving landscape of the biotechnology and pharmaceutical industries, Bio-Techne Corporation and Perrigo Company plc have emerged as key players. Over the past decade, Bio-Techne has seen a remarkable growth trajectory, with its revenue increasing by over 220% from 2014 to 2023. This growth is highlighted by a consistent upward trend, peaking at approximately $1.16 billion in 2023.

Conversely, Perrigo's revenue has shown a more stable pattern, with a slight dip in 2021 but maintaining a robust average of around $4.68 billion annually. Despite this stability, Perrigo's revenue in 2023 was approximately 75% higher than Bio-Techne's, showcasing its dominance in terms of sheer volume.

As we look to the future, the absence of data for Perrigo in 2024 leaves room for speculation. Will Bio-Techne continue its upward climb, or will Perrigo reclaim its growth momentum?